Chinese PLA General Hospital: Neoplasms trials

The registry lists 21 Neoplasms studies with Chinese PLA General Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 14Phase 2 10Phase 3 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Multimodal Artificial Intelligence for Detecting the Psychological State of Cancer PatientsEnrolling by invitationNCT07751757
• CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid TumorsNot yet recruitingNCT06939270Phase 1/2
• PIN in Combination With Anti-PD1 in Previously Treated Solid TumorRecruitingNCT06883149Phase 1
• CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid TumorsRecruitingNCT05947487Phase 1/2
• IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid TumorsRecruitingNCT05699811Phase 1/2
• Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid TumorsRecruitingNCT05693844Phase 1/2
• HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid TumorsRecruitingNCT05681650Phase 1/2
• Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid TumorsStatus unknownNCT06018142
• First in Human Study of 68Ga/64Cu-FAPI-XT117 PET/CT in Patients With Malignant Solid TumorsCompletedNCT05814835Phase 1
• TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid TumorsStatus unknownNCT04976218Phase 1
• Allogeneic γδ T Cell Therapy for the Treatment of Solid TumorsStatus unknownNCT04765462Phase 1/2
• Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid TumorsStatus unknownNCT04588324Phase 1/2
• Gastric Cancer Liver Metastasis Cohort of ChinaStatus unknownNCT04574245
• A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid TumorsStatus unknownNCT03787953
• Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid TumorsStatus unknownNCT03747965Phase 1
• Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors.Status unknownNCT03545815Phase 1
• Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast CarcinomaCompletedNCT02603016Not applicable
• Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary CancerStatus unknownNCT02159820Phase 2/3
• Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid TumorsStatus unknownNCT01935843Phase 1/2
• Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)Status unknownNCT01869166Phase 1/2
• Endoscopic Submucosal Dissection for Gastrointestinal NeoplasmsStatus unknownNCT01378507Not applicable